{"transactions":[{"id":848877,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Common Stock","published_at":"2026-03-11T20:01:55.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":10757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."}],"balance_after":74843,"source":{"system":"sec-edgar","filing":"0001628280-26-016795","document":"wk-form4_1773259312.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026016795/wk-form4_1773259312.xml","form_type":"4"}},{"id":848876,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-03-11T20:01:30.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":80666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."}],"balance_after":639583,"source":{"system":"sec-edgar","filing":"0001628280-26-016794","document":"wk-form4_1773259287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026016794/wk-form4_1773259287.xml","form_type":"4"}},{"id":922115,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Common Stock","published_at":"2026-02-03T21:17:23.000Z","date":"2026-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."}],"balance_after":85600,"source":{"system":"sec-edgar","filing":"0001628280-26-005018","document":"wk-form4_1770153440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026005018/wk-form4_1770153440.xml","form_type":"4"}},{"id":922116,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-03T21:16:46.000Z","date":"2026-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."}],"balance_after":720249,"source":{"system":"sec-edgar","filing":"0001628280-26-005014","document":"wk-form4_1770153401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026005014/wk-form4_1770153401.xml","form_type":"4"}},{"id":1084184,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":77340,"kind":"person","name":"Baum Bryan Daniel","position":1,"cik":"0002077411","reported_name":"Baum Bryan Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-21T17:56:55.000Z","date":"2025-07-18","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 18, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":1.95,"expiration_date":"2035-07-18","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0001854270-25-000083","document":"wk-form4_1753135011.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2077411/000185427025000083/wk-form4_1753135011.xml","form_type":"4"}},{"id":1100382,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T23:55:15.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":21950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":21950,"derivative":{"exercise_price":2.05,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":21950},"source":{"system":"sec-edgar","filing":"0000950170-25-091158","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025091158/ownership.xml","form_type":"4"}},{"id":1100517,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":23032,"kind":"person","name":"Schulz Fran","position":1,"cik":"0002046804","reported_name":"Schulz Fran","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T23:53:44.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":21950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":21950,"derivative":{"exercise_price":2.05,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":21950},"source":{"system":"sec-edgar","filing":"0000950170-25-091155","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046804/000095017025091155/ownership.xml","form_type":"4"}},{"id":1100381,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T23:53:28.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":21950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":21950,"derivative":{"exercise_price":2.05,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":21950},"source":{"system":"sec-edgar","filing":"0000950170-25-091154","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025091154/ownership.xml","form_type":"4"}},{"id":1100380,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":76045,"kind":"person","name":"Tang Donald F","position":1,"cik":"0001817370","reported_name":"Tang Donald F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T23:51:53.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":21950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":21950,"derivative":{"exercise_price":2.05,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":21950},"source":{"system":"sec-edgar","filing":"0000950170-25-091150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025091150/ownership.xml","form_type":"4"}},{"id":1100379,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":24544,"kind":"person","name":"Mathers Edward T","position":1,"cik":"0001328625","reported_name":"Mathers Edward T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T23:02:08.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":21950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":21950,"derivative":{"exercise_price":2.05,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":21950},"source":{"system":"sec-edgar","filing":"0000950170-25-091134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025091134/ownership.xml","form_type":"4"}},{"id":1100518,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78068,"kind":"person","name":"Hsiung Feng","position":1,"cik":"0002059159","reported_name":"Hsiung Feng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-27T19:55:03.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":21950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2026 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":21950,"derivative":{"exercise_price":2.05,"expiration_date":"2035-06-24","underlying":"Common Stock","underlying_shares":21950},"source":{"system":"sec-edgar","filing":"0000950170-25-091157","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059159/000095017025091157/ownership.xml","form_type":"4"}},{"id":1205844,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":81979,"kind":"organization","name":"Celadon Partners SPV 24","position":1,"cik":"0002060465","reported_name":"Celadon Partners SPV 24","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2025-03-14T15:52:40.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":9777,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9777000},"source":{"system":"sec-edgar","filing":"0001079973-25-000394","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000107997325000394/ownership.xml","form_type":"4"}},{"id":1205843,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":81979,"kind":"organization","name":"Celadon Partners SPV 24","position":1,"cik":"0002060465","reported_name":"Celadon Partners SPV 24","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-14T15:52:40.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":9777000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 9,777,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."}],"balance_after":9777000,"source":{"system":"sec-edgar","filing":"0001079973-25-000394","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000107997325000394/ownership.xml","form_type":"4"}},{"id":1209957,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":74499,"kind":"person","name":"New Enterprise Associates 15, L.P.","position":1,"cik":"0001629794","reported_name":"New Enterprise Associates 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74500,"kind":"person","name":"NEA Partners 15, L.P.","position":2,"cik":"0001640031","reported_name":"NEA Partners 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74501,"kind":"person","name":"NEA 15 GP, LLC","position":3,"cik":"0001640033","reported_name":"NEA 15 GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61210,"kind":"person","name":"BASKETT FOREST","position":4,"cik":"0001277631","reported_name":"BASKETT FOREST","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23293,"kind":"person","name":"Florence Anthony A. Jr.","position":5,"cik":"0001559827","reported_name":"Florence Anthony A. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23295,"kind":"person","name":"Makhzoumi Mohamad","position":6,"cik":"0001630226","reported_name":"Makhzoumi Mohamad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23294,"kind":"person","name":"SANDELL SCOTT D","position":7,"cik":"0001237289","reported_name":"SANDELL SCOTT D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2025-03-13T01:30:38.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":3333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 3,333,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 3,333,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 3,333,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 3,333,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by New Enterprise Associates 15, L.P. (\"NEA 15\") and are indirectly held by NEA Partners 15, L.P. (\"NEA Partners 15\"), the sole general partner of NEA 15, NEA 15 GP, LLC (\"NEA 15 GP\"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP (collectively, the \"Managers\") together, the \"Indirect Reporting Persons\"). The Mangers are Forest Baskett, Anthony Florence, Jr., Mohamad Makhzoumi, and Scott Sandell. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Indirect Reporting Persons have no pecuniary interest."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3333000},"source":{"system":"sec-edgar","filing":"0000950170-25-038280","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025038280/ownership.xml","form_type":"4"}},{"id":1209956,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":74499,"kind":"person","name":"New Enterprise Associates 15, L.P.","position":1,"cik":"0001629794","reported_name":"New Enterprise Associates 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74500,"kind":"person","name":"NEA Partners 15, L.P.","position":2,"cik":"0001640031","reported_name":"NEA Partners 15, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":74501,"kind":"person","name":"NEA 15 GP, LLC","position":3,"cik":"0001640033","reported_name":"NEA 15 GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":61210,"kind":"person","name":"BASKETT FOREST","position":4,"cik":"0001277631","reported_name":"BASKETT FOREST","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23293,"kind":"person","name":"Florence Anthony A. Jr.","position":5,"cik":"0001559827","reported_name":"Florence Anthony A. Jr.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23295,"kind":"person","name":"Makhzoumi Mohamad","position":6,"cik":"0001630226","reported_name":"Makhzoumi Mohamad","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":23294,"kind":"person","name":"SANDELL SCOTT D","position":7,"cik":"0001237289","reported_name":"SANDELL SCOTT D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-13T01:30:38.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":3333000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") was convertible into 1,000 shares of Common Stock either (i) automatically, at the Issuer's option or (ii) upon the election of the holder. On March 10, 2025, the Issuer exercised its right to automatically convert each share of Series A Preferred Stock, resulting in the acquisition of 3,333,000 shares of Common Stock. The Series A Preferred Stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities are directly held by New Enterprise Associates 15, L.P. (\"NEA 15\") and are indirectly held by NEA Partners 15, L.P. (\"NEA Partners 15\"), the sole general partner of NEA 15, NEA 15 GP, LLC (\"NEA 15 GP\"), the sole general partner of NEA Partners 15, and the individual managers of NEA 15 GP (NEA Partners 15, NEA 15 GP and the individual managers of NEA 15 GP (collectively, the \"Managers\") together, the \"Indirect Reporting Persons\"). The Mangers are Forest Baskett, Anthony Florence, Jr., Mohamad Makhzoumi, and Scott Sandell. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by NEA 15 in which the Indirect Reporting Persons have no pecuniary interest."}],"balance_after":3775615,"source":{"system":"sec-edgar","filing":"0000950170-25-038280","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025038280/ownership.xml","form_type":"4"}},{"id":1210318,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":82086,"kind":"organization","name":"BAYER HEALTHCARE LLC","position":1,"cik":"0001231517","reported_name":"BAYER HEALTHCARE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82087,"kind":"organization","name":"Bayer US Holding LP","position":2,"cik":"0001965754","reported_name":"Bayer US Holding LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82088,"kind":"organization","name":"Bayer World Investments B.V.","position":3,"cik":"0001820027","reported_name":"Bayer World Investments B.V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82089,"kind":"person","name":"BAYER AKTIENGESELLSCHAFT","position":4,"cik":"0001144145","reported_name":"BAYER AKTIENGESELLSCHAFT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2025-03-12T20:31:26.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":2222,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") automatically converted into 1,000 shares of the Issuer's common stock on the first trading day following the announcement of the Issuer's stockholders approval of the issuance of the Issuer's common stock upon conversion of the shares of Series A, which such announcement occurred on March 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities include shares of Series A and warrants purchased by the reporting person for $2,250 per unit. Each unit consists of one share of Series A, convertible into 1,000 shares of the Issuer's common stock, and accompanying warrant coverage to purchase 1,500 shares of the Issuer's common stock for each share of Series A purchased."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") automatically converted into 1,000 shares of the Issuer's common stock on the first trading day following the announcement of the Issuer's stockholders approval of the issuance of the Issuer's common stock upon conversion of the shares of Series A, which such announcement occurred on March 7, 2025."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") automatically converted into 1,000 shares of the Issuer's common stock on the first trading day following the announcement of the Issuer's stockholders approval of the issuance of the Issuer's common stock upon conversion of the shares of Series A, which such announcement occurred on March 7, 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is indirectly controlled by Bayer US Holding LP (\"BUSH LP\"), a Delaware limited partnership.  Bayer World Investments B.V. (\"BWI\"), a Dutch private limited company, is the general partner of BUSH LP.  BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC."}],"balance_after":0,"derivative":{"exercise_date":"2025-03-10","underlying":"Common Stock","underlying_shares":2222000},"source":{"system":"sec-edgar","filing":"0001578563-25-000173","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1144145/000157856325000173/primary_doc.xml","form_type":"4"}},{"id":1210317,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":82086,"kind":"organization","name":"BAYER HEALTHCARE LLC","position":1,"cik":"0001231517","reported_name":"BAYER HEALTHCARE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82087,"kind":"organization","name":"Bayer US Holding LP","position":2,"cik":"0001965754","reported_name":"Bayer US Holding LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82088,"kind":"organization","name":"Bayer World Investments B.V.","position":3,"cik":"0001820027","reported_name":"Bayer World Investments B.V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82089,"kind":"person","name":"BAYER AKTIENGESELLSCHAFT","position":4,"cik":"0001144145","reported_name":"BAYER AKTIENGESELLSCHAFT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T20:31:26.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":2222000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") automatically converted into 1,000 shares of the Issuer's common stock on the first trading day following the announcement of the Issuer's stockholders approval of the issuance of the Issuer's common stock upon conversion of the shares of Series A, which such announcement occurred on March 7, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") automatically converted into 1,000 shares of the Issuer's common stock on the first trading day following the announcement of the Issuer's stockholders approval of the issuance of the Issuer's common stock upon conversion of the shares of Series A, which such announcement occurred on March 7, 2025."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is indirectly controlled by Bayer US Holding LP (\"BUSH LP\"), a Delaware limited partnership.  Bayer World Investments B.V. (\"BWI\"), a Dutch private limited company, is the general partner of BUSH LP.  BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC."}],"balance_after":2809848,"source":{"system":"sec-edgar","filing":"0001578563-25-000173","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1144145/000157856325000173/primary_doc.xml","form_type":"4"}},{"id":1212503,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":24544,"kind":"person","name":"Mathers Edward T","position":1,"cik":"0001328625","reported_name":"Mathers Edward T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:28:11.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0000950170-25-037187","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017025037187/ownership.xml","form_type":"4"}},{"id":1212501,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Series A Convertible Preferred Stock","published_at":"2025-03-11T20:23:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":false,"shares":33,"price":2250,"value":74250.0,"ownership":{"direct":false,"nature":"Iyer Family Revocable Trust dated Aug 26 2012"},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares of Series A Convertible Preferred Stock have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person and her spouse are trustees of the Iyer Family Revocable Trust dated Aug 26 2012. Each of the reporting person and her spouse have voting and dispositive power over the Series A Preferred Stock, Common Stock and Warrants. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":2.25,"exercise_date":"2025-03-10","underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001854270-25-000034","document":"wk-form4_1741724618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000034/wk-form4_1741724618.xml","form_type":"4"}},{"id":1212500,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Common Stock","published_at":"2025-03-11T20:23:45.000Z","date":"2025-03-10","kind":"exercise","planned":false,"acquired":true,"shares":33000,"price":2.25,"value":74250.0,"ownership":{"direct":false,"nature":"Iyer Family Revocable Trust dated Aug 26 2012"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person and her spouse are trustees of the Iyer Family Revocable Trust dated Aug 26 2012. Each of the reporting person and her spouse have voting and dispositive power over the Series A Preferred Stock, Common Stock and Warrants. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001854270-25-000034","document":"wk-form4_1741724618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000034/wk-form4_1741724618.xml","form_type":"4"}},{"id":1212831,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":23032,"kind":"person","name":"Schulz Fran","position":1,"cik":"0002046804","reported_name":"Schulz Fran","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:21:02.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0001854270-25-000032","document":"wk-form4_1741724456.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046804/000185427025000032/wk-form4_1741724456.xml","form_type":"4"}},{"id":1212499,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:20:53.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0001854270-25-000031","document":"wk-form4_1741724446.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000031/wk-form4_1741724446.xml","form_type":"4"}},{"id":1212502,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":76045,"kind":"person","name":"Tang Donald F","position":1,"cik":"0001817370","reported_name":"Tang Donald F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:20:44.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0001854270-25-000030","document":"wk-form4_1741724435.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000030/wk-form4_1741724435.xml","form_type":"4"}},{"id":1212498,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:20:31.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest on the first anniversary of the date of grant, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0001854270-25-000029","document":"wk-form4_1741724422.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000029/wk-form4_1741724422.xml","form_type":"4"}},{"id":1212497,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":82127,"kind":"person","name":"Cross John Harry III","position":1,"cik":"0001806763","reported_name":"Cross John Harry III","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T20:14:50.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":174200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest on March 3, 2026 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":174200,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":174200},"source":{"system":"sec-edgar","filing":"0001854270-25-000026","document":"wk-form4_1741724083.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000026/wk-form4_1741724083.xml","form_type":"4"}},{"id":1212870,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78068,"kind":"person","name":"Hsiung Feng","position":1,"cik":"0002059159","reported_name":"Hsiung Feng","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-11T16:17:16.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":43900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from March 7, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":43900,"derivative":{"exercise_price":3.52,"expiration_date":"2035-03-06","underlying":"Common Stock","underlying_shares":43900},"source":{"system":"sec-edgar","filing":"0001854270-25-000028","document":"wk-form4_1741724230.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2059159/000185427025000028/wk-form4_1741724230.xml","form_type":"4"}},{"id":1215218,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-10T23:02:52.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":235088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F2","text":"The option grant was approved by the Issuer's board of directors on December 20, 2024, subject to shareholder approval of the Amended and Restated Plan, under which the option was granted. The Issuer's shareholders approved the Amended and Restated Plan on March 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Three-forty-eighth of the shares underlying this option vest on March 31, 2025 (\"Vesting Commencement Date\") and thereafter one-forty-eighth of the shares underlying this option vest in equal monthly installments from the Vesting Commencement Date, such that the option will be fully vested on the date forty-five months after the Vesting Commencement Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":235088,"derivative":{"exercise_price":3.97,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":235088},"source":{"system":"sec-edgar","filing":"0001854270-25-000015","document":"wk-form4_1741647766.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000015/wk-form4_1741647766.xml","form_type":"4"}},{"id":1215217,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Common Stock","published_at":"2025-03-10T23:02:52.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":78363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan, as amended and restated (the \"Amended and Restated Plan\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from March 7, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":86984,"source":{"system":"sec-edgar","filing":"0001854270-25-000015","document":"wk-form4_1741647766.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000015/wk-form4_1741647766.xml","form_type":"4"}},{"id":1215216,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Interim  PFO and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-10T23:01:31.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":1927073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The option grant was approved by the Issuer's board of directors on December 20, 2024, subject to shareholder approval of the Amended and Restated Plan, under which the option was granted. The Issuer's shareholders approved the Amended and Restated Plan on March 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Three-forty-eighth of the shares underlying this option vest on March 31, 2025 (\"Vesting Commencement Date\") and thereafter one-forty-eighth of the shares underlying this option vest in equal monthly installments from the Vesting Commencement Date, such that the option will be fully vested on the date forty-five months after the Vesting Commencement Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":1927073,"derivative":{"exercise_price":3.97,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":1927073},"source":{"system":"sec-edgar","filing":"0001854270-25-000013","document":"wk-form4_1741647685.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000013/wk-form4_1741647685.xml","form_type":"4"}},{"id":1215215,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Interim  PFO and PAO"}}],"security":"Common Stock","published_at":"2025-03-10T23:01:31.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":642358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan, as amended and restated (the \"Amended and Restated Plan\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from March 7, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":724440,"source":{"system":"sec-edgar","filing":"0001854270-25-000013","document":"wk-form4_1741647685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000013/wk-form4_1741647685.xml","form_type":"4"}},{"id":1280403,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-07T01:23:37.000Z","date":"2025-02-06","kind":"sale","planned":false,"acquired":false,"shares":545,"price":4.36,"value":2376.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":82082,"source":{"system":"sec-edgar","filing":"0001854270-25-000004","document":"wk-form4_1738891411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000004/wk-form4_1738891411.xml","form_type":"4"}},{"id":1280402,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-07T01:23:37.000Z","date":"2025-02-04","kind":"sale","planned":false,"acquired":false,"shares":3922,"price":4.07,"value":15962.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":82627,"source":{"system":"sec-edgar","filing":"0001854270-25-000004","document":"wk-form4_1738891411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000004/wk-form4_1738891411.xml","form_type":"4"}},{"id":1280401,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Common Stock","published_at":"2025-02-07T00:53:06.000Z","date":"2025-02-06","kind":"sale","planned":false,"acquired":false,"shares":182,"price":4.37,"value":795.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":8621,"source":{"system":"sec-edgar","filing":"0001854270-25-000002","document":"wk-form4_1738889580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000002/wk-form4_1738889580.xml","form_type":"4"}},{"id":1280400,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Common Stock","published_at":"2025-02-07T00:53:06.000Z","date":"2025-02-04","kind":"sale","planned":false,"acquired":false,"shares":1297,"price":4.07,"value":5278.79,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":8803,"source":{"system":"sec-edgar","filing":"0001854270-25-000002","document":"wk-form4_1738889580.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000002/wk-form4_1738889580.xml","form_type":"4"}},{"id":1336212,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":82086,"kind":"organization","name":"BAYER HEALTHCARE LLC","position":1,"cik":"0001231517","reported_name":"BAYER HEALTHCARE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82087,"kind":"organization","name":"Bayer US Holding LP","position":2,"cik":"0001965754","reported_name":"Bayer US Holding LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82088,"kind":"organization","name":"Bayer World Investments B.V.","position":3,"cik":"0001820027","reported_name":"Bayer World Investments B.V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82089,"kind":"person","name":"BAYER AKTIENGESELLSCHAFT","position":4,"cik":"0001144145","reported_name":"BAYER AKTIENGESELLSCHAFT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant","published_at":"2024-12-11T19:38:16.000Z","date":"2024-12-09","kind":"purchase","planned":false,"acquired":true,"shares":3333000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities include shares of Series A and warrants purchased by the reporting person for $2,250 per unit. Each unit consists of one share of Series A, convertible into 1,000 shares of the Issuer's common stock, and accompanying warrant coverage to purchase 1,500 shares of the Issuer's common stock for each share of Series A purchased."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The warrant becomes exercisable once the Issuer's stockholders first approve the issuance of the Issuer's common stock underlying the warrants in excess of the limitations imposed by Rule 5635 of the Nasdaq Stock Market listing rules."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is indirectly controlled by Bayer US Holding LP (\"BUSH LP\"), a Delaware limited partnership.  Bayer World Investments B.V. (\"BWI\"), a Dutch private limited company, is the general partner of BUSH LP.  BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC."}],"balance_after":3330000,"derivative":{"exercise_price":2.3,"expiration_date":"2029-12-09","underlying":"Common Stock","underlying_shares":3333000},"source":{"system":"sec-edgar","filing":"0001578563-24-000493","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1144145/000157856324000493/primary_doc.xml","form_type":"4"}},{"id":1336211,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":82086,"kind":"organization","name":"BAYER HEALTHCARE LLC","position":1,"cik":"0001231517","reported_name":"BAYER HEALTHCARE LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82087,"kind":"organization","name":"Bayer US Holding LP","position":2,"cik":"0001965754","reported_name":"Bayer US Holding LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82088,"kind":"organization","name":"Bayer World Investments B.V.","position":3,"cik":"0001820027","reported_name":"Bayer World Investments B.V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":82089,"kind":"person","name":"BAYER AKTIENGESELLSCHAFT","position":4,"cik":"0001144145","reported_name":"BAYER AKTIENGESELLSCHAFT","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-12-11T19:38:16.000Z","date":"2024-12-09","kind":"purchase","planned":false,"acquired":true,"shares":2222,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") will convert into 1,000 shares of the Issuer's common stock upon the date that the Issuer's stockholders first approve the issuance of the Issuer's common stock upon conversion of the shares of Series A."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported securities include shares of Series A and warrants purchased by the reporting person for $2,250 per unit. Each unit consists of one share of Series A, convertible into 1,000 shares of the Issuer's common stock, and accompanying warrant coverage to purchase 1,500 shares of the Issuer's common stock for each share of Series A purchased."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") will convert into 1,000 shares of the Issuer's common stock upon the date that the Issuer's stockholders first approve the issuance of the Issuer's common stock upon conversion of the shares of Series A."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") will convert into 1,000 shares of the Issuer's common stock upon the date that the Issuer's stockholders first approve the issuance of the Issuer's common stock upon conversion of the shares of Series A."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Each share of Series A Convertible Preferred Stock (\"Series A\") will convert into 1,000 shares of the Issuer's common stock upon the date that the Issuer's stockholders first approve the issuance of the Issuer's common stock upon conversion of the shares of Series A."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"The securities reported are held directly by Bayer HealthCare LLC, a Delaware limited liability company, which is indirectly controlled by Bayer US Holding LP (\"BUSH LP\"), a Delaware limited partnership.  Bayer World Investments B.V. (\"BWI\"), a Dutch private limited company, is the general partner of BUSH LP.  BWI is an indirect, wholly owned subsidiary of Bayer Aktiengesellschaft, a publicly-held German stock corporation. Accordingly, Bayer Aktiengesellschaft may be deemed to be an indirect beneficial owner of the shares beneficially owned directly by Bayer HealthCare LLC."}],"balance_after":2222,"derivative":{"underlying":"Common Stock","underlying_shares":2222000},"source":{"system":"sec-edgar","filing":"0001578563-24-000493","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1144145/000157856324000493/primary_doc.xml","form_type":"4"}},{"id":1337322,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":76045,"kind":"person","name":"Tang Donald F","position":1,"cik":"0001817370","reported_name":"Tang Donald F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-10T21:19:06.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from December 9, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":6.52,"expiration_date":"2034-12-08","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001854270-24-000125","document":"wk-form4_1733865539.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000125/wk-form4_1733865539.xml","form_type":"4"}},{"id":1337520,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":23032,"kind":"person","name":"Schulz Fran","position":1,"cik":"0002046804","reported_name":"Schulz Fran","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-10T21:17:33.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from December 9, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":12500,"derivative":{"exercise_price":6.52,"expiration_date":"2034-12-08","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001854270-24-000123","document":"wk-form4_1733865447.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2046804/000185427024000123/wk-form4_1733865447.xml","form_type":"4"}},{"id":1337321,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Common Stock Warrant (right to buy)","published_at":"2024-12-10T21:15:53.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Iyer Family Revocable Trust dated Aug 26 2012"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The warrant is exercisable for Common Stock at an exercise price per share equal to $2.30 (subject to adjustment as set forth in the warrant attached as Exhibit 4.1 to the Form 8-K) (the \"Warrant\"). The Warrant is exercisable at any time and from time to time on or after the Stockholder Approval (as defined in the Warrant) and on or prior to the five year anniversary of the original issuance date. The Warrant cannot be exercised by the Reporting Persons if, after giving effect thereto, the Reporting Person, together with his/her affiliates, would beneficially own, as determined in accordance with Section 13(d) of the U.S. Securities Exchange Act of 1934, as amended, more than 4.99%  of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise, subject to certain exceptions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The warrant is exercisable for Common Stock at an exercise price per share equal to $2.30 (subject to adjustment as set forth in the warrant attached as Exhibit 4.1 to the Form 8-K) (the \"Warrant\"). The Warrant is exercisable at any time and from time to time on or after the Stockholder Approval (as defined in the Warrant) and on or prior to the five year anniversary of the original issuance date. The Warrant cannot be exercised by the Reporting Persons if, after giving effect thereto, the Reporting Person, together with his/her affiliates, would beneficially own, as determined in accordance with Section 13(d) of the U.S. Securities Exchange Act of 1934, as amended, more than 4.99%  of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise, subject to certain exceptions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The warrant is exercisable for Common Stock at an exercise price per share equal to $2.30 (subject to adjustment as set forth in the warrant attached as Exhibit 4.1 to the Form 8-K) (the \"Warrant\"). The Warrant is exercisable at any time and from time to time on or after the Stockholder Approval (as defined in the Warrant) and on or prior to the five year anniversary of the original issuance date. The Warrant cannot be exercised by the Reporting Persons if, after giving effect thereto, the Reporting Person, together with his/her affiliates, would beneficially own, as determined in accordance with Section 13(d) of the U.S. Securities Exchange Act of 1934, as amended, more than 4.99%  of the number of shares of the Common Stock outstanding immediately after giving effect to such exercise, subject to certain exceptions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reporting person and her spouse are trustees of the Iyer Family Revocable Trust dated Aug 26 2012. Each of the reporting person and her spouse have voting and dispositive power over the Series A Preferred Stock, Common Stock and Warrants. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":49500,"derivative":{"exercise_price":2.3,"underlying":"Common Stock","underlying_shares":49500},"source":{"system":"sec-edgar","filing":"0001854270-24-000121","document":"wk-form4_1733865346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000121/wk-form4_1733865346.xml","form_type":"4"}},{"id":1337320,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Pres. & Chief Med. & Dev. Off."}}],"security":"Series A Convertible Preferred Stock","published_at":"2024-12-10T21:15:53.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":33,"price":2250,"value":74250.0,"ownership":{"direct":false,"nature":"Iyer Family Revocable Trust dated Aug 26 2012"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Conversion Price of the Series A Preferred Stock is subject to adjustment as set forth in that certain of Designation of Preferences, Rights and Limitations of the Series A Convertible Voting Preferred Stock attached as Exhibit 3.1 (the \"Certificate of Designation\") to the Issuer's Form 8-K filed with the Securities and Exchange Commission on December 2, 2024 (the \"Form 8-K\"). Capitalized terms that are used but not defined in this Form 4 have the meanings given to them in the Certificate of Designation."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of Series A Preferred Stock are not convertible until the stockholders of the Issuer approve the Proposals as set forth in Section 8 of the Certificate of Designation. Additionally, on the Automatic Conversion Date, as set forth in the Certificate of Designation, each share of Series A Preferred Stock shall automatically convert into 1,000 shares of Common Stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares of Series A Convertible Preferred Stock have no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"The shares of Series A Preferred Stock are not convertible until the stockholders of the Issuer approve the Proposals as set forth in Section 8 of the Certificate of Designation. Additionally, on the Automatic Conversion Date, as set forth in the Certificate of Designation, each share of Series A Preferred Stock shall automatically convert into 1,000 shares of Common Stock."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The shares of Series A Preferred Stock are not convertible until the stockholders of the Issuer approve the Proposals as set forth in Section 8 of the Certificate of Designation. Additionally, on the Automatic Conversion Date, as set forth in the Certificate of Designation, each share of Series A Preferred Stock shall automatically convert into 1,000 shares of Common Stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The reporting person and her spouse are trustees of the Iyer Family Revocable Trust dated Aug 26 2012. Each of the reporting person and her spouse have voting and dispositive power over the Series A Preferred Stock, Common Stock and Warrants. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":33,"derivative":{"exercise_price":2.25,"underlying":"Common Stock","underlying_shares":33000},"source":{"system":"sec-edgar","filing":"0001854270-24-000121","document":"wk-form4_1733865346.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000121/wk-form4_1733865346.xml","form_type":"4"}},{"id":1455377,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":24544,"kind":"person","name":"Mathers Edward T","position":1,"cik":"0001328625","reported_name":"Mathers Edward T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-12T20:30:25.000Z","date":"2024-07-10","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2025 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.31,"expiration_date":"2034-07-09","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0000950170-24-083230","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095017024083230/ownership.xml","form_type":"4"}},{"id":1455376,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":65668,"kind":"person","name":"Farokhzad Omid","position":1,"cik":"0001586852","reported_name":"Farokhzad Omid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-12T20:17:24.000Z","date":"2024-07-10","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2025 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.31,"expiration_date":"2034-07-09","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-24-000087","document":"wk-form4_1720815436.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000087/wk-form4_1720815436.xml","form_type":"4"}},{"id":1455375,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-12T20:16:29.000Z","date":"2024-07-10","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2025 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.31,"expiration_date":"2034-07-09","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-24-000085","document":"wk-form4_1720815383.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000085/wk-form4_1720815383.xml","form_type":"4"}},{"id":1455372,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-12T20:15:28.000Z","date":"2024-07-10","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2025 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.31,"expiration_date":"2034-07-09","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-24-000083","document":"wk-form4_1720815321.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000083/wk-form4_1720815321.xml","form_type":"4"}},{"id":1662070,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical & Devt. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T22:29:00.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":152000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":152000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":152000},"source":{"system":"sec-edgar","filing":"0001854270-24-000017","document":"wk-form4_1706912927.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000017/wk-form4_1706912927.xml","form_type":"4"}},{"id":1662069,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical & Devt. Officer"}}],"security":"Common Stock","published_at":"2024-02-02T22:29:00.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":101000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":101000,"source":{"system":"sec-edgar","filing":"0001854270-24-000017","document":"wk-form4_1706912927.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000017/wk-form4_1706912927.xml","form_type":"4"}},{"id":1662068,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T22:27:09.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":459000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":459000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":459000},"source":{"system":"sec-edgar","filing":"0001854270-24-000015","document":"wk-form4_1706912814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000015/wk-form4_1706912814.xml","form_type":"4"}},{"id":1662067,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-02-02T22:27:09.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":306000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":865496,"source":{"system":"sec-edgar","filing":"0001854270-24-000015","document":"wk-form4_1706912814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000015/wk-form4_1706912814.xml","form_type":"4"}},{"id":1662066,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Financial Officer","other_text":"Head of Corporate Development"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T22:24:38.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":152000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":152000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":152000},"source":{"system":"sec-edgar","filing":"0001854270-24-000013","document":"wk-form4_1706912660.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000013/wk-form4_1706912660.xml","form_type":"4"}},{"id":1662065,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":true,"officer_title":"Chief Financial Officer","other_text":"Head of Corporate Development"}}],"security":"Common Stock","published_at":"2024-02-02T22:24:38.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":101000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":131000,"source":{"system":"sec-edgar","filing":"0001854270-24-000013","document":"wk-form4_1706912660.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000013/wk-form4_1706912660.xml","form_type":"4"}},{"id":1848002,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":24544,"kind":"person","name":"Mathers Edward T","position":1,"cik":"0001328625","reported_name":"Mathers Edward T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T23:24:52.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the\napplicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.99,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-23-038925","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000120919123038925/doc4.xml","form_type":"4"}},{"id":1848001,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":112067,"kind":"person","name":"Berland Susan D","position":1,"cik":"0001307002","reported_name":"Berland Susan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T23:14:48.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.99,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-23-000077","document":"wk-form4_1687389279.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000077/wk-form4_1687389279.xml","form_type":"4"}},{"id":1848000,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T23:13:48.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.99,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-23-000076","document":"wk-form4_1687389217.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000076/wk-form4_1687389217.xml","form_type":"4"}},{"id":1847999,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T23:12:04.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.99,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-23-000074","document":"wk-form4_1687389110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000074/wk-form4_1687389110.xml","form_type":"4"}},{"id":1847998,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":65668,"kind":"person","name":"Farokhzad Omid","position":1,"cik":"0001586852","reported_name":"Farokhzad Omid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-21T23:10:20.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares underlying this option vest upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the 2024 Annual Meeting, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":0.99,"expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001854270-23-000072","document":"wk-form4_1687389009.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000072/wk-form4_1687389009.xml","form_type":"4"}},{"id":2036480,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T22:20:57.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":130000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001854270-23-000019","document":"wf-form4_167537644193252.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000019/wf-form4_167537644193252.xml","form_type":"4"}},{"id":2036479,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical & Devt. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T22:20:39.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":130000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001854270-23-000018","document":"wf-form4_167537642370409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000018/wf-form4_167537642370409.xml","form_type":"4"}},{"id":2036478,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T22:20:19.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":630000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":630000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":630000},"source":{"system":"sec-edgar","filing":"0001854270-23-000017","document":"wf-form4_167537640361956.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000017/wf-form4_167537640361956.xml","form_type":"4"}},{"id":2036590,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":117384,"kind":"person","name":"Lee Philip J","position":1,"cik":"0001931711","reported_name":"Lee Philip J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technology Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T17:21:17.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":195000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001854270-23-000020","document":"wf-form4_167537646100811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1931711/000185427023000020/wf-form4_167537646100811.xml","form_type":"4"}},{"id":2144994,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:47:13.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option vest on September 20, 2023 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":240000,"derivative":{"exercise_price":2.5,"expiration_date":"2032-10-02","underlying":"Common Stock","underlying_shares":240000},"source":{"system":"sec-edgar","filing":"0001854270-22-000036","document":"wf-form4_166491640953549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427022000036/wf-form4_166491640953549.xml","form_type":"4"}},{"id":2144993,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78258,"kind":"person","name":"KNOBELMAN DEBORAH","position":1,"cik":"0001931509","reported_name":"KNOBELMAN DEBORAH","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-10-04T20:47:13.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award will vest on September 20, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001854270-22-000036","document":"wf-form4_166491640953549.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427022000036/wf-form4_166491640953549.xml","form_type":"4"}},{"id":2204606,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61524,"kind":"person","name":"Rajangam Kanya","position":1,"cik":"0001816676","reported_name":"Rajangam Kanya","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical & Devt. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-20T22:00:12.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":327750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option vest on July 5, 2023 and the remainder vest in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":327750,"derivative":{"exercise_price":1.8,"expiration_date":"2032-07-17","underlying":"Common Stock","underlying_shares":327750},"source":{"system":"sec-edgar","filing":"0000899243-22-026420","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000089924322026420/doc4.xml","form_type":"4"}},{"id":2207127,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":24544,"kind":"person","name":"Mathers Edward T","position":1,"cik":"0001328625","reported_name":"Mathers Edward T","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T22:09:58.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":125000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-07-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001209191-22-042301","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000120919122042301/doc4.xml","form_type":"4"}},{"id":2207125,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":65668,"kind":"person","name":"Farokhzad Omid","position":1,"cik":"0001586852","reported_name":"Farokhzad Omid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T22:00:32.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":125000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-07-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-026140","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000089924322026140/doc4.xml","form_type":"4"}},{"id":2207126,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":78050,"kind":"person","name":"Collins James J.","position":1,"cik":"0001779269","reported_name":"Collins James J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T22:00:30.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":125000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-07-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-026141","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000089924322026141/doc4.xml","form_type":"4"}},{"id":2207124,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":112067,"kind":"person","name":"Berland Susan D","position":1,"cik":"0001307002","reported_name":"Berland Susan D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T22:00:30.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":125000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-07-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-026139","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000089924322026139/doc4.xml","form_type":"4"}},{"id":2207123,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":1546,"kind":"person","name":"Epstein David R","position":1,"cik":"0001445826","reported_name":"Epstein David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T22:00:25.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":125000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-07-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-026138","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000089924322026138/doc4.xml","form_type":"4"}},{"id":2207122,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":34711,"kind":"person","name":"COOPERSTONE BRENDA","position":1,"cik":"0001931514","reported_name":"COOPERSTONE BRENDA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T22:00:19.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission."}],"balance_after":125000,"derivative":{"exercise_price":1.75,"expiration_date":"2032-07-12","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-026137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000089924322026137/doc4.xml","form_type":"4"}},{"id":2236349,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":1546,"kind":"person","name":"Epstein David R","position":1,"cik":"0001445826","reported_name":"Epstein David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2022-06-11T01:22:43.000Z","date":"2022-06-08","kind":"exercise","acquired":false,"shares":112519,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Upon the consummation of the business combination described in footnote 1, the Sponsor distributed 123,252 shares of common stock of the Issuer to David Epstein."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":112519},"source":{"system":"sec-edgar","filing":"0000950103-22-010425","document":"dp175101_4-epstein.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095010322010425/dp175101_4-epstein.xml","form_type":"4"}},{"id":2236348,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":1546,"kind":"person","name":"Epstein David R","position":1,"cik":"0001445826","reported_name":"Epstein David R","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:22:43.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":112519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Prior to the distribution described in footnote 2, the Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who held an economic interest therein. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, requires unanimous approval of the managers. The shares reported were attributable to Mr. Epstein's equity ownership interest of the Sponsor."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."}],"balance_after":123252,"source":{"system":"sec-edgar","filing":"0000950103-22-010425","document":"dp175101_4-epstein.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095010322010425/dp175101_4-epstein.xml","form_type":"4"}},{"id":2236347,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":65668,"kind":"person","name":"Farokhzad Omid","position":1,"cik":"0001586852","reported_name":"Farokhzad Omid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2022-06-11T01:21:12.000Z","date":"2022-06-08","kind":"exercise","acquired":false,"shares":5750000,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the distribution described in footnote 2, the Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Omid Farokhzad's beneficial ownership interest in the Sponsor is held indirectly through Dynamics Group, LLC. Mr. Farokhzad controls and is the sole member of Dynamics Group, LLC. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, required unanimous approval of the managers. Mr. Farokhzad disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. As described in footnote 2, 4,518,097 of the shares held by the Sponsor (after subtracting the 1,947,403 distributed to Dynamics Group, LLC) were either forfeited by Sponsor or distributed to other members of the Sponsor."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5750000},"source":{"system":"sec-edgar","filing":"0000950103-22-010424","document":"dp175102_4-omid.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095010322010424/dp175102_4-omid.xml","form_type":"4"}},{"id":2236346,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":65668,"kind":"person","name":"Farokhzad Omid","position":1,"cik":"0001586852","reported_name":"Farokhzad Omid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:21:12.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":250000,"price":10,"value":2500000.0,"ownership":{"direct":false,"nature":"OCF 2014 Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"OCF 2014 Trust is the record owner of these shares. Mr. Farokhzad (and/or his family members) have an economic interest in the OCF 2014 Trust. Mr. Farokhzad disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein."}],"balance_after":250000,"source":{"system":"sec-edgar","filing":"0000950103-22-010424","document":"dp175102_4-omid.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095010322010424/dp175102_4-omid.xml","form_type":"4"}},{"id":2236345,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":65668,"kind":"person","name":"Farokhzad Omid","position":1,"cik":"0001586852","reported_name":"Farokhzad Omid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:21:12.000Z","date":"2022-06-08","kind":"other","acquired":false,"shares":4518097,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Dynamics Group, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Prior to the distribution described in footnote 2, the Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Omid Farokhzad's beneficial ownership interest in the Sponsor is held indirectly through Dynamics Group, LLC. Mr. Farokhzad controls and is the sole member of Dynamics Group, LLC. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, required unanimous approval of the managers. Mr. Farokhzad disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. As described in footnote 2, 4,518,097 of the shares held by the Sponsor (after subtracting the 1,947,403 distributed to Dynamics Group, LLC) were either forfeited by Sponsor or distributed to other members of the Sponsor."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"shares","element":"transactionShares","label":"F3","text":"Prior to the distribution described in footnote 2, the Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Omid Farokhzad's beneficial ownership interest in the Sponsor is held indirectly through Dynamics Group, LLC. Mr. Farokhzad controls and is the sole member of Dynamics Group, LLC. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, required unanimous approval of the managers. Mr. Farokhzad disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. As described in footnote 2, 4,518,097 of the shares held by the Sponsor (after subtracting the 1,947,403 distributed to Dynamics Group, LLC) were either forfeited by Sponsor or distributed to other members of the Sponsor."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Upon the consummation of the business combination described in footnote 1, the Sponsor distributed 1,947,403 shares of Issuer's common stock to Dynamics Group, LLC. Omid Farokhzad controls and is the sole member of Dynamics Group, LLC. The Sponsor's remaining interests in the Issuer (the 4,518,097 shares reported herein) were either forfeited by Sponsor or distributed to other members of the Sponsor."}],"balance_after":1947403,"source":{"system":"sec-edgar","filing":"0000950103-22-010424","document":"dp175102_4-omid.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095010322010424/dp175102_4-omid.xml","form_type":"4"}},{"id":2236344,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":65668,"kind":"person","name":"Farokhzad Omid","position":1,"cik":"0001586852","reported_name":"Farokhzad Omid","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-11T01:21:12.000Z","date":"2022-06-08","kind":"exercise","acquired":true,"shares":5750000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"shares","element":"transactionShares","label":"F3","text":"Prior to the distribution described in footnote 2, the Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Omid Farokhzad's beneficial ownership interest in the Sponsor is held indirectly through Dynamics Group, LLC. Mr. Farokhzad controls and is the sole member of Dynamics Group, LLC. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, required unanimous approval of the managers. Mr. Farokhzad disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. As described in footnote 2, 4,518,097 of the shares held by the Sponsor (after subtracting the 1,947,403 distributed to Dynamics Group, LLC) were either forfeited by Sponsor or distributed to other members of the Sponsor."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date. 329,386 shares of Class A common stock (to which Dynamics Group, LLC was otherwise entitled) were forfeited in connection therewith."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Prior to the distribution described in footnote 2, the Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Omid Farokhzad's beneficial ownership interest in the Sponsor is held indirectly through Dynamics Group, LLC. Mr. Farokhzad controls and is the sole member of Dynamics Group, LLC. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, required unanimous approval of the managers. Mr. Farokhzad disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. As described in footnote 2, 4,518,097 of the shares held by the Sponsor (after subtracting the 1,947,403 distributed to Dynamics Group, LLC) were either forfeited by Sponsor or distributed to other members of the Sponsor."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Upon the consummation of the business combination described in footnote 1, the Sponsor distributed 1,947,403 shares of Issuer's common stock to Dynamics Group, LLC. Omid Farokhzad controls and is the sole member of Dynamics Group, LLC. The Sponsor's remaining interests in the Issuer (the 4,518,097 shares reported herein) were either forfeited by Sponsor or distributed to other members of the Sponsor."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the distribution described in footnote 2, the Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi who hold an economic interest therein. Omid Farokhzad's beneficial ownership interest in the Sponsor is held indirectly through Dynamics Group, LLC. Mr. Farokhzad controls and is the sole member of Dynamics Group, LLC. Any action by the Sponsor with respect to Issuer or the shares reported above, including voting and dispositive decisions, required unanimous approval of the managers. Mr. Farokhzad disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein. As described in footnote 2, 4,518,097 of the shares held by the Sponsor (after subtracting the 1,947,403 distributed to Dynamics Group, LLC) were either forfeited by Sponsor or distributed to other members of the Sponsor."}],"balance_after":6465500,"source":{"system":"sec-edgar","filing":"0000950103-22-010424","document":"dp175102_4-omid.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000095010322010424/dp175102_4-omid.xml","form_type":"4"}},{"id":2236382,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":126314,"kind":"person","name":"Dynamics Sponsor LLC","position":1,"cik":"0001863972","reported_name":"Dynamics Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2022-06-10T21:20:32.000Z","date":"2022-06-08","kind":"exercise","acquired":false,"shares":5750000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":5750000},"source":{"system":"sec-edgar","filing":"0000950103-22-010423","document":"dp175103_4-dyn.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1863972/000095010322010423/dp175103_4-dyn.xml","form_type":"4"}},{"id":2236381,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":126314,"kind":"person","name":"Dynamics Sponsor LLC","position":1,"cik":"0001863972","reported_name":"Dynamics Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T21:20:32.000Z","date":"2022-06-08","kind":"other","acquired":false,"shares":6465500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950103-22-010423","document":"dp175103_4-dyn.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1863972/000095010322010423/dp175103_4-dyn.xml","form_type":"4"}},{"id":2236380,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":126314,"kind":"person","name":"Dynamics Sponsor LLC","position":1,"cik":"0001863972","reported_name":"Dynamics Sponsor LLC","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T21:20:32.000Z","date":"2022-06-08","kind":"exercise","acquired":true,"shares":5750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share that Dynamics Sponsor LLC, a Delaware limited liability company (the \"Sponsor\"), held as record holder of Class B common stock, par value $0.0001, automatically converted into one share of Class A common stock, par value $0.0001, at the closing of the Issuer's initial business combination on June 8, 2022, and, pursuant to the Issuer's amended certificate of incorporation which came into effect on such date, shares of Class A common stock became shares of common stock (without class designation), par value $0.0001, of the Issuer at such time. The shares of Class B common stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In connection with the business combination, following the conversion of Class B common stock into Class A common stock, 871,028 shares of Class A common stock were forfeited by the Sponsor. Subsequent to the forfeiture described in the preceding sentence, the Sponsor distributed all shares of Class A common stock held by it to its members, which include Dynamics Group, LLC, an entity which Omid Farokhzad controls and is the sole member of, and David Epstein."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F3","text":"The Sponsor was the record holder of these shares. The Sponsor is governed by a board of managers consisting of Omid Farokhzad and Mostafa Ronaghi."}],"balance_after":6465500,"source":{"system":"sec-edgar","filing":"0000950103-22-010423","document":"dp175103_4-dyn.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1863972/000095010322010423/dp175103_4-dyn.xml","form_type":"4"}}]}